Expression of HAT1 and HDAC1, 2, 3 in Diffuse Large B-Cell Lymphomas, Peripheral T-Cell Lymphomas, and NK/T-Cell Lymphomas
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: It has generally been proven that histone acetylation and deacetylation are involved in the malignant transformation. To date, however, this has rarely been studied in cases of malignant lymphoma. Methods: We studied nine cases of reactive lymphoid hyperplasia, 78 cases of diffuse large B-cell lymphoma (DLBCL), 13 cases of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), and 13 cases of extranodal NK/T-cell lymphoma, nasal type (NKTCL). Thus, we attempted to elucidate the associations of the degree of the expression of histone acetyltransferase 1 (HAT1), histone deacetylase (HDAC) 1, HDAC2, and HDAC3 with the clinical behaviors of above malignant lymphomas using the immunohistochemistry and a western blot analysis. Results: The degree of the expression of HAT1 was higher in cases of DLBCL, PTCL-NOS or NKTCL as compared with reactive lymphoid hyperplasia (p<0.05). The degree of the expression of HAT1 was correlated with that of HDAC1 in cases of DLBCL or NKTCL (p<0.05). The degree of the expression of HAT1 and HDAC1 was correlated with a poor survival in cases of DLBCL or PTCL-NOS (p>0.05). Conclusions: HAT1, HDAC1, and HDAC2 play a critical role in the development of malignant lymphomas. Both HAT1 and HDAC1 might be indicators for a poor prognosis in cases of DLBCL as cooperating factors.
Abstract
Background: It has generally been proven that histone acetylation and deacetylation are involved in the malignant transformation. To date, however, this has rarely been studied in cases of malignant lymphoma. Methods: We studied nine cases of reactive lymphoid hyperplasia, 78 cases of diffuse large B-cell lymphoma (DLBCL), 13 cases of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), and 13 cases of extranodal NK/T-cell lymphoma, nasal type (NKTCL). Thus, we attempted to elucidate the associations of the degree of the expression of histone acetyltransferase 1 (HAT1), histone deacetylase (HDAC) 1, HDAC2, and HDAC3 with the clinical behaviors of above malignant lymphomas using the immunohistochemistry and a western blot analysis. Results: The degree of the expression of HAT1 was higher in cases of DLBCL, PTCL-NOS or NKTCL as compared with reactive lymphoid hyperplasia (p<0.05). The degree of the expression of HAT1 was correlated with that of HDAC1 in cases of DLBCL or NKTCL (p<0.05). The degree of the expression of HAT1 and HDAC1 was correlated with a poor survival in cases of DLBCL or PTCL-NOS (p>0.05). Conclusions: HAT1, HDAC1, and HDAC2 play a critical role in the development of malignant lymphomas. Both HAT1 and HDAC1 might be indicators for a poor prognosis in cases of DLBCL as cooperating factors.
참고문헌 (27)
- Orr JA, "Histone acetylation and chromatin pattern in cancer: a review", Anal Quant Cytol Histol, 29, pp.17~31 (2007)
- Agata Y, "Histone acetylation determines the developmentally regulated accessibility for T cell receptor gamma gene recombination", J Exp Med, 193, pp.873~880 (2001)
- Ropero S, "The role of histone deacetylases (HDACs) in human cancer", Mol Oncol, 1, pp.19~25 (2007)
- Yasui W, "Histone acetylation and gastrointestinal carcinogenesis", Ann N Y Acad Sci, 983, pp.220~231 (2003)
- Glass CK, "The coregulator exchange in transcriptional functions of nuclear receptors", Genes Dev, 14, pp.121~141 (2000)
- Lin RJ, "Transcriptional regulation in acute promyelocytic leukemia", Oncogene, 20, pp.7204~7215 (2001)
- Johnstone RW, "Histone-deacetylase inhibitors: novel drugs for the treatment of cancer", Nat Rev Drug Discov, 1, pp.287~299 (2002)
- Dhordain P, "The LAZ3(BCL-6) oncoprotein recruits a SMRT", mSIN3A, Nucleic Acids Res, pp.1998, 26[DOI]
- Peinado H, "Snail mediates E-cadherin repression by the recruitment of the Sin3A", histone deacetylase 1 (HDAC1), Mol Cell Biol, pp.2004, 24[DOI]
- Hajra KM, "Cadherin and catenin alterations in human cancer", Genes Chromosomes Cancer, 34, pp.255~268 (2002)
- Azimzadeh O, "Formalin-fixed paraffin-embedded (FFPE) proteome analysis using gel-free and gel-based proteomics", J Proteome Res, 9, pp.4710~4720 (2010)
- Park Y, "Normal prion protein in Drosophila enhances the toxicity of pathogenic polyglutamine proteins and alters susceptibility to oxidative and autophagy signaling modulators", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 404(2), pp.638~645 (2011), ACADEMIC PRESS INC ELSEVIER SCIENCE
- Jones PA, "The fundamental role of epigenetic events in cancer", Nat Rev Genet, 3, pp.415~428 (2002)
- 윤선옥, "Diffuse Large B Cell Lymphoma Shows Distinct MethylationProfiles of the Tumor Suppressor Genes among theNon-Hodgkin’s Lymphomas", The Korean Journal of Pathology, 42(1), pp.16~20 (2008), 대한병리학회
- 최재훈, "Expression profile of histone deacetylase 1 in gastric cancer tissues", Japanese Journal of Cancer Research, 92(12), pp.1300~1304 (2001), Oxford University Press
- Halkidou K, "Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer", Prostate, 59, pp.177~189 (2004)
- Mariadason JM, "HDACs and HDAC inhibitors in colon cancer", Epigenetics, 3, pp.28~37 (2008)
- Ishihama K, "Expression of HDAC1 and CBP", p300 in human colorectal carcinomas, 2007, pp.60, 1205~1210
- Zhang Z, "Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast", Breast Cancer Res Treat, 94, pp.11~16 (2005)
- Huang BH, "Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1", WAF1 expression, independent of histone deacetylase 1, 2005, pp.12, 395~404
- Song J, "Increased expression of histone deacetylase 2 is found in human gastric cancer", APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 113(4), pp.264~268 (2005), Blackwell Publishing Inc.
- Zhu P, "Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis", Cancer Cell, 5, pp.455~463 (2004)
- Wilson AJ, "Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer", J Biol Chem, 281, pp.13548~13558 (2006)
- Marquard L, "Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas", Histopathology, 54, pp.688~698 (2009)
- Marquard L, "Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma", Histopathology, 53, pp.267~277 (2008)
- Sugimoto T, "Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation", Biochem Biophys Res Commun, 390, pp.48~53 (2009)
- Gloghini A, "Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors", Br J Haematol, 147, pp.515~525 (2009)